咨询与建议

限定检索结果

文献类型

  • 3 篇 期刊文献

馆藏范围

  • 3 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 3 篇 医学
    • 3 篇 临床医学

主题

  • 2 篇 cholangiocarcino...
  • 1 篇 biliary tumor
  • 1 篇 hepatocellular c...
  • 1 篇 intraluminal bra...
  • 1 篇 获得性耐药
  • 1 篇 fgfr1
  • 1 篇 cholangiocarcino...
  • 1 篇 hepatic tumor
  • 1 篇 成纤维细胞生长因...
  • 1 篇 疾病进展
  • 1 篇 biliary tract
  • 1 篇 radiofrequency a...
  • 1 篇 抗肿瘤活性
  • 1 篇 fgfr2
  • 1 篇 extrahepatic
  • 1 篇 肝内胆管癌
  • 1 篇 共价结合
  • 1 篇 hepatocellular c...

机构

  • 1 篇 department of ga...
  • 1 篇 department of ra...
  • 1 篇 department of in...
  • 1 篇 department of ga...
  • 1 篇 department of ga...
  • 1 篇 department of en...

作者

  • 1 篇 rtika r abraham
  • 1 篇 funda meric-bern...
  • 1 篇 赵义军
  • 1 篇 renu madan
  • 1 篇 divya khosla
  • 1 篇 耿小平
  • 1 篇 rajnish mishra
  • 1 篇 shikha goyal
  • 1 篇 tara keihanian
  • 1 篇 samreen zaheer
  • 1 篇 rahul gupta
  • 1 篇 rakesh kapoor
  • 1 篇 mohit girotra
  • 1 篇 richard hendriqu...
  • 1 篇 cholangiocarcino...
  • 1 篇 antoine hollebec...
  • 1 篇 narendra kumar
  • 1 篇 jatinder goyal

语言

  • 2 篇 英文
  • 1 篇 中文
检索条件"作者=Cholangiocarcinoma Lipika goyal"
3 条 记 录,以下是1-10 订阅
排序:
Futibatinib治疗FGFR22重排肝内胆管癌
收藏 引用
肝胆外科杂志 2023年 第2期31卷 86-86页
作者: cholangiocarcinoma lipika goyal Funda Meric-Bernstam Antoine Hollebecque 赵义军(摘译) 耿小平(审校) 不详
背景:成纤维细胞生长因子受体2(FGFR2)改变已成为治疗肝内胆管癌的潜在希望靶点。Futibatinib是新一代、共价结合的FGFR1-4抑制剂,已被证明对FCFR改变的肿瘤患者具有抗肿瘤活性,并对与ATP竞争性FGFR抑制剂相关的获得性耐药突变具有很强... 详细信息
来源: 维普期刊数据库 维普期刊数据库 评论
Radiofrequency ablation in the management of primary hepatic and biliary tumors
收藏 引用
World Journal of Gastrointestinal Oncology 2022年 第1期14卷 203-215页
作者: Richard Hendriquez Tara Keihanian Jatinder goyal Rtika R Abraham Rajnish Mishra Mohit Girotra Department of Internal Medicine University of Central FloridaOrlandoFL 32816United States Department of Gastroenterology and Hepatology University of MiamiMiamiFL 33136United States Department of Gastroenterology and Hepatology Wellspan Digestive Health-York HospitalYorkPA 17403United States Department of Endocrinology Swedish Medical CenterSeattleWA 98104United States
In the United States,80%-90%of primary hepatic tumors are hepatocellular carcinomas and 10%-15%are cholangiocarcinomas(CCA),both with high mortality rate,particularly CCA,which portends a worse *** management with sur... 详细信息
来源: 维普期刊数据库 维普期刊数据库 评论
Role of intraluminal brachytherapy in palliation of biliary obstruction in cholangiocarcinoma:A brief review
收藏 引用
World Journal of Gastrointestinal Endoscopy 2022年 第3期14卷 106-112页
作者: Divya Khosla Samreen Zaheer Rahul Gupta Renu Madan Shikha goyal Narendra Kumar Rakesh Kapoor Department of Radiotherapy and Oncology Postgraduate Institute of Medical Educa Department of Gastroenterology and Hepatology Shalby Multispeciality HospitalMohali 160062PunjabIndiation and ResearchChandigarh 160012U.T.India
Surgery is the only curative treatment for cholangiocarcinoma. However, mostpatients present with advanced disease, and hence are unresectable. Thus, theintent of treatment shifts from curative to palliative in the ma... 详细信息
来源: 维普期刊数据库 维普期刊数据库 评论